News & Events

Learn about the actions of our company.

Newborn Screening in Greece: How Revvity’s QSight 225 MD UHPLC-MS/MS Is Expanding the National Program

At the Institute of Child Health in Athens, a new pilot is expanding Greece's 50-year-old newborn screening program, adding 29 metabolic disorders to the panel, powered by Revvity's QSight® 225 MD UHPLC-MS/MS system. Learn more.

More
Allergy and Autoimmune Diagnostics: Inside the Phadia, ImmunoCAP & EliA Platform

Allergy and autoimmune diagnostics increasingly run on the same automated platform. Learn how Thermo Fisher Scientific's Phadia laboratory systems power ImmunoCAP allergy testing and EliA autoimmunity testing, from benchtop to high-throughput.

More

We have partnered with leading manufacturers in the health care and lifesciences fields, worldwide.

See all suppliers
Ψηφιακός Μετασχηματισμός Μικρομεσαίων Επιχειρήσεων